Tasman Metals Announces REE Recovery in Excess of 90% within a Concentrate Mass Between 6% and 7% at Olserum Project
Radiopharm Theranostics Accelerates 177Lu-RAD204 Phase 1 Dose Escalation Clinical Trial Based on Positive Recommendation from Data Safety and Monitoring Committee
Finlay Minerals Appoints an Executive Chairman, President & CEO, and Vice President, Corporate Development
